Securitize to List on NYSE as BlackRock-Backed Tokenization Firm Completes SPAC
Tokenization specialist Securitize is set to complete its merger with a SPAC and begin trading on the NYSE next week under the ticker SECZ, pending shareholder approval. The BlackRock-backed firm aims to raise $400 million in the transaction.
Written by CoinArticle’s AI Newsroom · from 2 cited sources. How we work
Story Updates
- Updated Sep 19, 2026, 01:03 AM: Confirmed ticker symbol SECZ and $400 million raise target per latest CoinDesk reporting; closing expected next week pending shareholder vote.
SPAC Merger to Close Next Week
Securitize expects to complete its merger with a special-purpose acquisition company and commence public trading on the New York Stock Exchange next week, subject to shareholder approval. The company will trade under the ticker symbol SECZ, according to CoinDesk reporting.
Capital Raise and Market Position
The tokenization specialist aims to raise $400 million through the transaction. The merger represents a watershed moment for blockchain-based asset tokenization on Wall Street, as Securitize has built a platform to issue and manage tokenized securities, real-world assets, and fund shares on blockchain networks. BlackRock's backing of the firm underscores institutional appetite for tokenization infrastructure as traditional asset managers explore on-chain settlement and issuance.
Why It Matters
For Traders
NYSE listing of a tokenization-focused firm creates a publicly traded proxy to the sector; monitor opening-day volume and institutional ownership for conviction signals.
For Investors
A major asset manager backing and then exiting through a SPAC signals institutional tokenization infrastructure is transitioning from venture-backed startup to public utility.
For Builders
Securitize's public status may accelerate institutional adoption of the platforms it supports, creating tailwinds for protocols and stablecoins used in tokenized asset settlement.
This article is for information only and is not financial advice. Read the full disclaimer.
